PL332648A1 - Derivatives of n-(2-benzothiazolyl)-1-piperidinethane mine, their production and application in medical therapy - Google Patents

Derivatives of n-(2-benzothiazolyl)-1-piperidinethane mine, their production and application in medical therapy

Info

Publication number
PL332648A1
PL332648A1 PL97332648A PL33264897A PL332648A1 PL 332648 A1 PL332648 A1 PL 332648A1 PL 97332648 A PL97332648 A PL 97332648A PL 33264897 A PL33264897 A PL 33264897A PL 332648 A1 PL332648 A1 PL 332648A1
Authority
PL
Poland
Prior art keywords
piperidinethane
benzothiazolyl
mine
derivatives
production
Prior art date
Application number
PL97332648A
Inventor
Gihad Dargazanli
Pascal George
Patrick Lardenois
Jonathan Frost
Johannes Schoemaker
Maria-Carmen Renones
Pascale Magat
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of PL332648A1 publication Critical patent/PL332648A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PL97332648A 1996-10-01 1997-09-26 Derivatives of n-(2-benzothiazolyl)-1-piperidinethane mine, their production and application in medical therapy PL332648A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9611925A FR2753970B1 (en) 1996-10-01 1996-10-01 N- (BENZOTHIAZOL-2-YL) PIPERIDINE-1-ETHANAMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
PCT/FR1997/001692 WO1998014444A1 (en) 1996-10-01 1997-09-26 N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics

Publications (1)

Publication Number Publication Date
PL332648A1 true PL332648A1 (en) 1999-09-27

Family

ID=9496217

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97332648A PL332648A1 (en) 1996-10-01 1997-09-26 Derivatives of n-(2-benzothiazolyl)-1-piperidinethane mine, their production and application in medical therapy

Country Status (23)

Country Link
EP (1) EP0929550A1 (en)
JP (1) JP2001501217A (en)
KR (1) KR20000048767A (en)
CN (1) CN1230959A (en)
AR (1) AR009105A1 (en)
AU (1) AU722147B2 (en)
BG (1) BG103271A (en)
BR (1) BR9711842A (en)
CA (1) CA2266510A1 (en)
CO (1) CO4650030A1 (en)
CZ (1) CZ112699A3 (en)
EE (1) EE9900135A (en)
FR (1) FR2753970B1 (en)
HU (1) HUP9904091A3 (en)
IL (1) IL128902A (en)
NO (1) NO991581L (en)
NZ (1) NZ334553A (en)
PL (1) PL332648A1 (en)
SK (1) SK42299A3 (en)
TR (1) TR199900634T2 (en)
TW (1) TW438800B (en)
WO (1) WO1998014444A1 (en)
ZA (1) ZA978772B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
IL153278A0 (en) 2000-06-21 2003-07-06 Hoffmann La Roche Benzothiazole derivatives
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
RU2006117631A (en) * 2003-10-24 2007-12-10 Ф.Хоффманн-Ля Рош Аг (Ch) CCR3 RECEPTOR ANTAGONISTS
EA011279B1 (en) 2004-05-24 2009-02-27 Ф. Хоффманн-Ля Рош Аг 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2yl)-amide
US7459563B2 (en) 2004-11-05 2008-12-02 Hoffmann-La Roche Inc. Process for the preparation of isonicotinic acid derivatives
PL1863818T3 (en) 2005-03-23 2010-08-31 Hoffmann La Roche Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists
ES2340321T3 (en) 2005-09-27 2010-06-01 F.Hoffmann-La Roche Ag OXADIAZOLILPIRAZOLO-PIRIMIDINAS, AS ANGLGIST OF MGLUR2.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
KR930005004B1 (en) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. Process for preparing substituted n-|(4-piperidinyl) alkyl¨ bicycle condensed oxazole and thiazolamines

Also Published As

Publication number Publication date
TW438800B (en) 2001-06-07
NO991581D0 (en) 1999-03-30
KR20000048767A (en) 2000-07-25
JP2001501217A (en) 2001-01-30
AU722147B2 (en) 2000-07-20
FR2753970B1 (en) 1998-10-30
AR009105A1 (en) 2000-03-08
NO991581L (en) 1999-06-01
BR9711842A (en) 1999-08-24
TR199900634T2 (en) 1999-06-21
CZ112699A3 (en) 1999-06-16
EP0929550A1 (en) 1999-07-21
FR2753970A1 (en) 1998-04-03
IL128902A0 (en) 2000-02-17
WO1998014444A1 (en) 1998-04-09
ZA978772B (en) 1998-03-27
AU4463897A (en) 1998-04-24
EE9900135A (en) 1999-12-15
HUP9904091A3 (en) 2000-07-28
CA2266510A1 (en) 1998-04-09
HUP9904091A2 (en) 2000-05-28
CO4650030A1 (en) 1998-09-03
NZ334553A (en) 2000-11-24
SK42299A3 (en) 1999-12-10
IL128902A (en) 2001-07-24
BG103271A (en) 2000-05-31
CN1230959A (en) 1999-10-06

Similar Documents

Publication Publication Date Title
PL329411A1 (en) Novel derivatives of benzazepin, therapeutic agents containing such derivatives and their application in production of therapeutic agents
GB9613003D0 (en) N-oxides of morpholine derivatives and their use as therapeutic agents
GB9701206D0 (en) Serine derivatives and their use as therapeutic agents
AU6566094A (en) Heterocyclic derivatives in the treatment of ischaemia and related diseases
DE69524215D1 (en) RETRORE-REFLECTING BODY AND PRODUCTION METHOD
PL331863A1 (en) 7alpha-(xi-aminoalkyl)-estrathienes, method of obtaining them, pharmacautic preparations containing such compounds and their application in production of therapeutic agents
PL305543A1 (en) Derivatives of 1-amino ethylindole, method of obtaining them and therapeutic agents containming such derivatives
PL325691A1 (en) Derivatives of dithiolane, method of obtaining them and their therapeutic effects
AU3391395A (en) Morpholine derivatives and their use as therapeutic agents
PL311999A1 (en) Piperazine derivatives, therapeutic agents containing them and method of obtaining such derivatives
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
PL330235A1 (en) Derivatives of spiropiperidine and their application as therapeutic agents
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
PL321003A1 (en) Derivatives of piperasine, drugs containing them, their application and methods of obtaining them
AU6721598A (en) Dioxino derivatives and their use as therapeutic agents
PL328608A1 (en) Novel derivatives of erythromycin, method of obtaining them and their therapeutic application as drugs
PL321201A1 (en) Derivatives of 4-hydroxypiepridine, method of obtaining them and therapeutic agents containing such derivatives
PL327854A1 (en) Novel derivatives of benzoguanidin, method of obtaining them and their application in production of therapeutic agents
PL332643A1 (en) 1h-pyrido-[3,4-b]-indolo-4-carboxyamidic derivatives, their production and application in medical treatment
PL323177A1 (en) Azacycloalcane derivatives, method of obtaining them and their application for therapeutic purposes
PL332648A1 (en) Derivatives of n-(2-benzothiazolyl)-1-piperidinethane mine, their production and application in medical therapy
PL308074A1 (en) Derivatives of borone peptides, their production as well as their application in medical therapy
NO992676D0 (en) 1,4-Diazabicyclo [2,2,2] oct-2-ylmethyl derivatives, their preparation and therapeutic use
PL330257A1 (en) Novel heterocyclic derivatives of benzocycloalkene, method of obtaining them and therapeutic agent
EE03687B1 (en) Furandiarylmethylidene derivatives, method of their preparation and use in therapy